Ablative Solutions
PrivateLast Round
Series D
Dec 26, 2024
Total Funding Raised
$155.66M
Company Overview
Ablative Solutions is a medical device company that develops catheter-based neurolytic delivery systems for the treatment of uncontrolled hypertension.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ablative Solutions Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Ablative Solutions Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Dec 26, 2024 | ||||
| Early Stage VC | Jan 30, 2024 | ||||
| Series D | Jun 13, 2022 | ||||
| Series C | Jan 3, 2018 | ||||
| Series B | Feb 4, 2014 | ||||
Series A | Jun 19, 2012 |
Ablative Solutions Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioStar Equity | Series B, Series A |
| Gilde Healthcare | Series D |
| Invus Opportunities | Series D |
| Charter Capital Partners | Series D, Series B, Series A |
| BioStar Capital | Series A, Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 30, 2024
$29.3M raised in early stage VC funding.
Ablative Solutions Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ablative Solutions's valuation, stock price, and market status.